Dr. Peters brings over 30 years of experience, including 23 years in clinical development and commercialization through senior leadership roles within the pharmaceutical industry, as well as more than a decade of clinical and research experience in academic settings.

Before joining Veralox, Dr. Peters served as CEO, CSO, and CMO of various biotechnology startups. He was also the Chief Medical Officer at Realm Therapeutics and Therakos, where he led corporate strategy and execution across Global Clinical Development, Regulatory Affairs, Pharmacoeconomics, and Medical/Scientific Affairs.

Earlier in his career, Dr. Peters held multiple leadership roles at CSL Behring and its predecessor companies, with increasing responsibilities in Clinical Development, Regulatory, and Medical Affairs. He contributed significantly to clinical research across the Americas and held global responsibility for hemostasis and critical care therapeutic areas. During his tenure at CSL Behring, Dr. Peters was instrumental in securing FDA approval for seven products.

Prior to his industry career, Dr. Peters was a National Research Service Award (NRSA) Fellow at the University of Pennsylvania, a Fogarty International Fellow at the National Institutes of Health (NIH), and a resident at the University of Berlin in Germany. He earned both his MD and PhD from the University of Berlin.

• 

  Chief Medical Officer in Veralox Therapeutics

  Developing new therapies for life-threatening immuno-inflammatory diseases